Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

134.81
Delayed Data
As of 1:18pm ET
 -0.80 / -0.59%
Today’s Change
112.01
Today|||52-Week Range
169.89
-6.01%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close135.61
Today’s open135.23
Day’s range134.35 - 136.14
Volume149,360
Average volume (3 months)482,450
Market cap$5.9B
Data as of 1:18pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-16.18%
Earnings growth (next 5 years)-10.20%
Revenue growth (last year)+9.08%
P/E ratio11.9
Price/Sales4.20
Price/Book3.16

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.85+2.46%
GRFSGrifols SA-0.21-0.97%
CTLTCatalent Inc-0.50-1.26%
----
Data as of 1:31pm ET, 12/12/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$3.98
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts